Madrigal Pharmaceuticals CFO Executes $854K Stock Sale Amid Option Grant and Zero‑Value Share Award
Mardi Dier, Executive Vice President and CFO of Madrigal Pharmaceuticals (MDGL), completed the sale of 1,962 shares on March 6, 2026 under a pre-arranged Rule 10b5-1 plan, generating about $854,000. The trades came alongside an earlier March 4 acquisition of 5,215 shares with a recorded value of $0 and a grant of options to buy 6,519 shares at $434…